Collegium to Report Fourth Quarter and Full-Year 2024 Financial Results on February 27, 2025
Portfolio Pulse from
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) will release its Q4 and full-year 2024 financial results on February 27, 2025, followed by a conference call and webcast.
February 13, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Collegium Pharmaceutical is set to release its Q4 and full-year 2024 financial results on February 27, 2025. This announcement could impact the stock price based on the financial performance revealed.
The announcement of financial results is a significant event for investors as it provides insights into the company's performance. Depending on the results, the stock price could move up or down. However, without the actual results, the immediate impact is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100